WEBINAR REPLAY: Safety Profile of 2.5% iPAAG in Equine and Canine Patients

Описание: This comprehensive lecture provides veterinarians and animal health professionals with an evidence-based review of the safety considerations surrounding 2.5% injectable polyacrylamide hydrogel (iPAAG) in equine and canine patients.
Join Dr. Jason Lowe and Dr. Matt Brunke as they explore the mechanism of action, clinical indications, and safety data that informs treatment decisions for joint disease across species.
What You'll Learn:

How 2.5% iPAAG works at the cellular level
Clinical indications for horses and dogs
Comprehensive safety data and research findings
Practical considerations for clinical application
Cross-species insights from equine and canine cases

About the Presenters:
Dr. Matt Brunke, DVM, DACVSMR
Dr. Brunke is a diplomate of the American College of Veterinary Sports Medicine and Rehabilitation, practicing in the Washington, DC area. He received his DVM from Ross University School of Veterinary Medicine and completed certifications in rehabilitation, pain management, and acupuncture. As part of the founding faculty for the NC State CCAT Rehab program, Dr. Brunke brings a comprehensive, practical approach to orthopedic and neurological cases in canine patients.
Dr. Jason Lowe, MBA BVSc Cert EP
Chief Veterinary Officer at Contura Vet, Dr. Lowe brings over 30 years of clinical experience in specialist equine medicine. Based in Cambridge, New Zealand, he holds a veterinary degree from Massey University, a Certificate in Equine Practice from the Royal College, London, and an MBA from Waikato University. Dr. Lowe is actively engaged in research advancing equine performance medicine and improving outcomes for horses worldwide.